People who inject drugs should have access to hepatitis C treatment, expert panel recommends
People with HIV are at higher risk of several types of cancer, large study finds
New antiretrovirals and HIV treatment strategies highlighted at ICAAC
US HIV physicians routinely offering early ART but only a third have prescribed PrEP
Recent infection and ART treatment interruptions are key periods for HIV transmission
New HCV NS5A inhibitor EDP-239 looks good in early studies, more evidence supports early hepatitis C treatment
PrEP preferences in gay men are predicted by the frequency and predictability of the sex they have
WHO guidelines recommend universal antiretroviral treatment, PrEP for those at substantial risk
